Advanced Medical Solutions Group Plc (AMS.L), a company focused on tissue-healing technologies, on Wednesday reported an increase in preliminary revenue for the full year, helped by strong growth in US LiquiBand, other key surgical product categories, and the acquisitions of Peters Surgical and Syntacoll.
For the 12-month period to December 31, 2024, the Group recorded a pre-tax income of 9.823 million pounds, lower than the 21.157 million pounds of last year. The company noted that its earnings were impacted by acquisition and integration costs.
Adjusted pre-tax earnings were 29.4 million pounds as against the prior year's 25.9 million pounds.
Net profit declined to 7.094 million pounds, or 3.25 pence per share, from 15.889 million pounds, or 7.25 pence per share, in 2023. Adjusted earnings per share were 10.45 pence, higher than 9.05 pence per share in the previous year.
Operating profit slipped to 11.219 million pounds from 18.882 million pounds a year ago. Revenue was 177.521 million pounds, up from the previous year's 126.210 million pounds.
For the full-year 2024, the Board will pay a final dividend of 1.83 pence per share, resulting in a total dividend of 2.60 pence per share for 2024, which is higher than last year's 2.36 pence per share. The final dividend will be paid on June 20 to shareholders on the register as of May 30.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.